Patents by Inventor Michael A. Rudnicki

Michael A. Rudnicki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230114123
    Abstract: The present disclosure provides a method for stimulating asymmetric division of at least some satellite stem cells in a patient suffering from a disease or disorder characterized by satellite cells having an inability, or a reduced ability, to assemble a functional dystrophin-associated glycoprotein complex (DGC) that results in an inability, or reduced ability, to establish cell polarity. The method includes administering to the patient a sufficient amount of an epidermal growth factor receptor (EGFR) pathway activator to stimulate asymmetric division of at least some satellite stem cells.
    Type: Application
    Filed: October 6, 2022
    Publication date: April 13, 2023
    Applicant: Ottawa Hospital Research Institute
    Inventors: Michael A. Rudnicki, Yu Xin Wang
  • Patent number: 10828346
    Abstract: There are provided compositions and methods for modulating stem cell division decisions, in particular, division symmetry. It has been demonstrated that wnt7a acts through frizzled-7 receptor expressed on the surface of adult stem cells, e.g. satellite stem cells, to activate the planar cell polarity (PCP) pathway, thereby promoting symmetrical expansion of stem cells. The compositions and methods of the invention are useful, for example, in modulating stem cell division symmetry in vitro and in vivo, in replenishing and expanding the stem cell pool, and in promoting the formation, maintenance, repair and regeneration of tissue.
    Type: Grant
    Filed: August 10, 2018
    Date of Patent: November 10, 2020
    Assignee: Ottawa Hospital Research Institute
    Inventors: Michael A. Rudnicki, Fabien Le Grand
  • Publication number: 20200038485
    Abstract: The present disclosure provides a method for stimulating asymmetric division of at least some satellite stem cells in a patient suffering from a disease or disorder characterized by satellite cells having an inability, or a reduced ability, to assemble a functional dystrophin-associated glycoprotein complex (DGC) that results in an inability, or reduced ability, to establish cell polarity. The method includes administering to the patient a sufficient amount of an epidermal growth factor receptor (EGFR) pathway activator to stimulate asymmetric division of at least some satellite stem cells.
    Type: Application
    Filed: April 17, 2018
    Publication date: February 6, 2020
    Inventors: Michael A. Rudnicki, Xin Yu Wang
  • Publication number: 20180360913
    Abstract: There are provided compositions and methods for modulating stem cell division decisions, in particular, division symmetry. It has been demonstrated that wnt7a acts through frizzled-7 receptor expressed on the surface of adult stem cells, e.g. satellite stem cells, to activate the planar cell polarity (PCP) pathway, thereby promoting symmetrical expansion of stem cells. The compositions and methods of the invention are useful, for example, in modulating stem cell division symmetry in vitro and in vivo, in replenishing and expanding the stem cell pool, and in promoting the formation, maintenance, repair and regeneration of tissue.
    Type: Application
    Filed: August 10, 2018
    Publication date: December 20, 2018
    Applicant: OTTAWA HOSPITAL RESEARCH INSTITUTE
    Inventors: Michael A. Rudnicki, Fabien LE GRAND
  • Patent number: 10071138
    Abstract: There are provided compositions and methods for modulating stem cell division decisions, in particular, division symmetry. It has been demonstrated that wnt7a acts through frizzled-7 receptor expressed on the surface of adult stem cells, e.g. satellite stem cells, to activate the planar cell polarity (PCP) pathway, thereby promoting symmetrical expansion of stem cells. The compositions and methods of the invention are useful, for example, in modulating stem cell division symmetry in vitro and in vivo, in replenishing and expanding the stem cell pool, and in promoting the formation, maintenance, repair and regeneration of tissue.
    Type: Grant
    Filed: August 19, 2016
    Date of Patent: September 11, 2018
    Assignee: Ottawa Hospital Research Institute
    Inventors: Michael A. Rudnicki, Fabien Le Grand
  • Patent number: 9815413
    Abstract: A cargo carrier device supports cargo thereon for movement relative to a truck box between a loading position substantially at ground level rearward of the truck box and a transport position above the vehicle. The device includes a cargo frame defining a planar rack for supporting cargo thereon above a passenger cab of the truck in the transport position. A cargo supporting crossbar can be selectively positioned above the planar rack which is adapted to suspend cargo therefrom. A four bar linkage which pivots through an intermediate over-center position between the loading and transport positions is adapted to support the crossbar i) centrally above the truck box in the transport position and ii) rearward of the truck box and lower in elevation in the loading position for use in hoisting suspended cargo into the truck box.
    Type: Grant
    Filed: February 5, 2016
    Date of Patent: November 14, 2017
    Inventor: Michael Rudnicki
  • Patent number: 9732130
    Abstract: There are provided compositions and methods for modulating stem cell division, in particular, division symmetry. It has been demonstrated that Wnt7a polypeptide fragments promoting symmetrical expansion of stem cells. The compositions and methods of the invention are useful, for example, in modulating stem cell division symmetry in vitro, ex vivo, and in vivo, in replenishing and expanding the stem cell pool, and in promoting the formation, maintenance, repair and regeneration of tissue.
    Type: Grant
    Filed: September 14, 2012
    Date of Patent: August 15, 2017
    Assignee: Ottawa Hospital Research Institute
    Inventors: Michael A. Rudnicki, Conrad Florian Bentzinger, Radoslav Zinoviev
  • Publication number: 20170120833
    Abstract: A cargo carrier device supports cargo thereon for movement relative to a truck box between a loading position substantially at ground level rearward of the truck box and a transport position above the vehicle. The device includes a cargo frame defining a planar rack for supporting cargo thereon above a passenger cab of the truck in the transport position. A cargo supporting crossbar can be selectively positioned above the planar rack which is adapted to suspend cargo therefrom. A four bar linkage which pivots through an intermediate over-center position between the loading and transport positions is adapted to support the crossbar i) centrally above the truck box in the transport position and ii) rearward of the truck box and lower in elevation in the loading position for use in hoisting suspended cargo into the truck box.
    Type: Application
    Filed: February 5, 2016
    Publication date: May 4, 2017
    Inventor: Michael Rudnicki
  • Publication number: 20170087188
    Abstract: The invention provides cell therapy compositions and associated methods. In particular embodiments, improved therapeutic cells and improved cell-based gene therapies for promoting cell or tissue formation, regeneration, repair or maintenance in a subject in need thereof are provided.
    Type: Application
    Filed: March 27, 2015
    Publication date: March 30, 2017
    Inventors: Michael A. RUDNICKI, Conrad Florian BENTZINGER
  • Publication number: 20170042973
    Abstract: There are provided compositions and methods for modulating stem cell division decisions, in particular, division symmetry. It has been demonstrated that wnt7a acts through frizzled-7 receptor expressed on the surface of adult stem cells, e.g. satellite stem cells, to activate the planar cell polarity (PCP) pathway, thereby promoting symmetrical expansion of stem cells. The compositions and methods of the invention are useful, for example, in modulating stem cell division symmetry in vitro and in vivo, in replenishing and expanding the stem cell pool, and in promoting the formation, maintenance, repair and regeneration of tissue.
    Type: Application
    Filed: August 19, 2016
    Publication date: February 16, 2017
    Inventors: Michael A. Rudnicki, Fabien Le Grand
  • Publication number: 20160009373
    Abstract: A propeller assembly has a main hub and a propeller hub circumferentially movable relative to the main hub about a main axis of the assembly. Circumferentially spaced propeller blades on the propeller hub are i) circumferentially movable together with the propeller hub relative to the main hub between a first position and a second position against a biasing force, and ii) pivotal about respective radial axes. A pitch linkage mechanism is operatively connected between each propeller blade and the main hub such that each propeller blade is pivotal about the respective radial axis from a first pitch orientation to a second pitch orientation together with movement of the propeller hub relative to the main hub from the first position to the second position responsive to air resistance in the second direction exceeding the biasing force.
    Type: Application
    Filed: March 31, 2015
    Publication date: January 14, 2016
    Inventors: Andrew Kondor, Christopher Michael Rudnicki, Michael Anthony Rudnicki, Tyler J. F. Bragnalo
  • Publication number: 20150125427
    Abstract: The present invention provides novel stem cells, nucleotide sequences and proteins therefrom. More specifically, the present invention provides Pax7+/Myf5? stem cells and methods for identifying and isolating them. Also provided is a MEGF10 nucleotide sequence and protein.
    Type: Application
    Filed: February 14, 2014
    Publication date: May 7, 2015
    Applicant: Ottawa Health Research Institute
    Inventors: Michael A. Rudnicki, Shihuan Kuang, Chet Holterman
  • Patent number: 9018188
    Abstract: The present invention relates to microRNAs (miRNAs) that are associated with obesity. The present invention is directed to methods, compounds, and compositions for preventing and treating obesity, as well as related diseases, using a microRNA inhibitor.
    Type: Grant
    Filed: September 13, 2012
    Date of Patent: April 28, 2015
    Assignee: Ottawa Hospital Research Institute
    Inventors: Michael A. Rudnicki, Hang Yin
  • Publication number: 20150111822
    Abstract: There are provided compositions and methods for modulating stem cell division, in particular, division symmetry. It has been demonstrated that Wnt7a polypeptide fragments promoting symmetrical expansion of stem cells. The compositions and methods of the invention are useful, for example, in modulating stem cell division symmetry in vitro, ex vivo, and in vivo, in replenishing and expanding the stem cell pool, and in promoting the formation, maintenance, repair and regeneration of tissue.
    Type: Application
    Filed: September 14, 2012
    Publication date: April 23, 2015
    Inventors: Michael A. Rudnicki, Conrad Florian Bentzinger, Radoslav Zinoviev
  • Publication number: 20140290505
    Abstract: Waste objects, for example used oil barrels, are crushed using a device having a frame which supports first and second press plates so as to be movable towards one another in a crushing direction. A plurality of ball screw assemblies which are connected between the press plates each include a lead screw and a follower nut with roller elements in rolling engagement with the threads of the lead screw such that there is little or no static friction which must be overcome in order to release the press plate from the crushed object once the crushing operation is complete. A motor coupled to the ball screw assemblies applies a continuous torque throughout a full range of crushing movement of the second press plate relative to the first press plate to overcome the back pressure from the object being crushed.
    Type: Application
    Filed: March 28, 2014
    Publication date: October 2, 2014
    Inventor: Michael Rudnicki
  • Publication number: 20140221466
    Abstract: The present invention relates to microRNAs (miRNAs) that are associated with obesity. The present invention is directed to methods, compounds, and compositions for preventing and treating obesity, as well as related diseases, using a microRNA inhibitor.
    Type: Application
    Filed: September 13, 2012
    Publication date: August 7, 2014
    Applicant: OTTAWA HOSPITAL RESEARCH INSTITUTE
    Inventors: Michael A. Rudnicki, Hang Yin
  • Patent number: 8679833
    Abstract: The present invention provides novel stem cells, nucleotide sequences and proteins therefrom. More specifically, the present invention provides Pax7+/Myf5? stem cells and methods for identifying and isolating them. Also provided is a MEGF10 nucleotide sequence and protein.
    Type: Grant
    Filed: January 13, 2012
    Date of Patent: March 25, 2014
    Assignee: Ottawa Health Research Institute
    Inventors: Michael A. Rudnicki, Shihuan Kuang, Chet Holterman
  • Publication number: 20140051630
    Abstract: A method for regenerating pancreatic tissue using recombinant periostin protein, a nucleic acid encoding said periostin and pharmaceutical compositions comprising said periostin are disclosed. Isolation of a nucleic acid encoding a periostin isoform, panc, is also taught.
    Type: Application
    Filed: January 28, 2013
    Publication date: February 20, 2014
    Applicant: OTTAWA HOSPITAL RESEARCH INSTITUTE
    Inventors: Michael RUDNICKI, Johnathan SMID
  • Patent number: 8361960
    Abstract: A method for regenerating pancreatic tissue using recombinant periostin protein, a nucleic acid encoding said periostin and pharmaceutical compositions comprising said periostin are disclosed. Isolation of a nucleic acid encoding a periostin isoform, panc, is also taught.
    Type: Grant
    Filed: September 8, 2009
    Date of Patent: January 29, 2013
    Assignee: Ottawa Hospital Research Institute
    Inventors: Michael Rudnicki, Johnathan Smid
  • Publication number: 20120213751
    Abstract: The present invention provides novel stem cells, nucleotide sequences and proteins therefrom. More specifically, the present invention provides Pax7+/Myf5? stem cells and methods for identifying and isolating them. Also provided is a MEGF10 nucleotide sequence and protein.
    Type: Application
    Filed: January 13, 2012
    Publication date: August 23, 2012
    Applicant: OTTAWA HEALTH RESEARCH INSTITUTE
    Inventors: Michael A. Rudnicki, Shihuan Kuang, Chet Holterman